University of Cambridge

We are starting to see how robots can play sous-chef in kitchens around the world. But some scientists are exploring how they might not only do some of the heavy lifting, but actually elevate the dining experience for the humans they serve.

Scientists have designed a novel antibody that can accurately detect the toxic protein oligomers suspected to cause the degeneration associated with Alzheimer’s disease. The breakthrough hopes to lead to improved drug design and clinical testing.

Scientists in the UK have tapped 25 years worth of Census data to track the habits and health outcomes of hundreds of thousands of commuters, finding an association between those who avoid daily car travel and a lower risk of early death.

Scientists in the UK have developed a new AI algorithm that could help narrow the margin for error in diagnosing brain injuries, with the ability to detect and categorize different types of lesions to gauge the extent of the damage.

A new study has uncovered a possible new tool for diagnosing severe brain injuries, with an inexpensive “sniff test” demonstrating the potential to predict those that will go on to regain consciousness further down the track.

Heart cells don’t naturally replenish, so after a heart attack it stays permanently damaged. Cambridge researchers have now stumbled onto genes that appear to trigger heart cell regeneration – and they did so by accident, while researching cancer.

Comparing the eco-credentials of electric cars and their gasoline-powered counterparts isn’t as simple as counting the carbon emissions coming (or not) from the tailpipe. New research is claiming to have settled the debate once and for all.

Scientists at the University of Cambridge have launched what they describe as the the world's first licensed, downloadable artificial pancreas smartphone app, to help in the safe administering of insulin to sufferers of type 1 diabetes.

A new imaging study has found neuroinflammation may be more common in neurodegenerative diseases than previously suspected. The Cambridge research revealed brain inflammation to be a common thread across three different types of dementia.

When Parkinson’s patients are diagnosed with the condition, there are still many unknowns around how the disease will impact their lives. While it is no crystal ball, a new blood test is offering hope of better patient management.

A novel clinical trial from an international team of researchers has found a cheap, generic drug may effectively moderate the severity of symptoms associated with autism spectrum disorder (ASD) in children.

A new solar-powered catalyst made of graphene and titanium dioxide nanoparticles can pluck pollutants out of the air, much more efficiently than others. The catalyst could be coated onto building or street surfaces to improve air quality in cities.